What question did this study set out to answer?

The research aims to develop a high-performance electrochemical sensing platform for monitoring psychotropic drugs using ZrO2 @MWCNTs.

May 6, 2026Open Access

Zirconium dioxide-decorated MWCNTs (ZrO 2 @MWCNTs) nanocomposite as a high-performance electrochemical sensing platform for psychotropic drug analysis

Key Points

The research aims to develop a high-performance electrochemical sensing platform for monitoring psychotropic drugs using ZrO2 @MWCNTs.
Developed a nanocomposite based on zirconium dioxide-decorated MWCNTs.
Tested the electrochemical performance for psychotropic drug analysis.
Evaluated cost-effectiveness and efficiency of the sensing platform.
Demonstrated rapid detection of psychotropic drugs with high accuracy.
Showed potential for cost-effective implementation in pharmaceutical settings.
Indicated efficacy for real-time monitoring in point-of-care testing.

Abstract

@MWCNTs-based electrochemical sensing platform represents a rapid, cost-effective, and efficient approach for psychotropic drug monitoring, with considerable potential for future implementation in pharmaceutical analysis and point-of-care testing (POCT) applications.

Zirconium dioxide-decorated MWCNTs (ZrO 2 @MWCNTs) nanocomposite as a high-performance electrochemical sensing platform for psychotropic drug analysis

Key Points

Abstract

Cite This Study